Ubs Group Ag Cryo Cell International Inc Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$4.19 - $6.6 $3,104 - $4,890	741 New	741 $4,000
Q1 2023 May 12, 2023	SELL	$2.97 - $4.66 $4,594 - $7,209	-1,547 Reduced 89.73%	177 $0
Q4 2022 Feb 08, 2023	BUY	$4.12 - $6.5 $6,538 - $10,315	1,587 Added 1158.39%	1,724 $7,000
Q3 2022 Nov 10, 2022	SELL	$5.2 - $7.53 $686 - $993	-132 Reduced 49.07%	137 $1,000
Q2 2022 Aug 10, 2022	SELL	$5.83 - $7.71 $6,762 - $8,943	-1,160 Reduced 81.18%	269 $2,000
Q1 2022 May 16, 2022	BUY	$7.28 - $11.84 $10,374 - $16,872	1,425 Added 35625.0%	1,429 $11,000
Q4 2021 Feb 14, 2022	SELL	$11.27 - $13.9 $1,667 - $2,057	-148 Reduced 97.37%	4 $0
Q3 2021 Nov 15, 2021	BUY	$8.97 - $14.16 $1,363 - $2,152	152 New	152 $2,000

902K

Ticker CCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 8,519,250
Market Cap $63.9M
Description
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.